Rapid detection of anti-hepatitis A virus neutralizing antibodies in a microplate enzyme immunoassay

References

1. Beales L. P., Wood D. J., Minor P. D., Saldanha J. A. 1996; A novel cytopathic microtitre plate assay for hepatitis A virus and anti-hepatitis A neutralizing antibodies. J Virol Methods 59:147–154 [CrossRef]
   [Google Scholar]
2. Bishop N. E., Anderson D. A. 1997; Early interactions of hepatitis A virus with cultured cells: viral elution and the effect of pH and calcium ions. Arch Virol 142:2161–2178 [CrossRef]
   [Google Scholar]
3. Bordignon J., Comin F., Ferreira S. C., Caporale G. M., Lima Filho J. H., Zanetti C. R. 2002a; Calculating rabies virus neutralizing antibodies titres by flow cytometry. Rev Inst Med Trop Sao Paulo 44:151–154 [CrossRef]
   [Google Scholar]
4. Bordignon J., Pires Ferreira S. C., Medeiros Caporale G. M., Carrieri M. L., Kotait I., Lima H. C., Zanetti C. R. 2002b; Flow cytometry assay for intracellular rabies virus detection. J Virol Methods 105:181–186 [CrossRef]
   [Google Scholar]
5. Brack K., Frings W., Dotzauer A., Vallbracht A. 1998; A cytopathogenic, apoptosis-inducing variant of hepatitis A virus. J Virol 72:3370–3376
   [Google Scholar]
6. Brown F. 1989; The classification and nomenclature of viruses: summary of results of meetings of the International Committee on Taxonomy of Viruses in Edmonton, Canada 1987. Intervirology 30:181–186
   [Google Scholar]
7. Cao J., Meng S., Li C., Ji Y., Meng Q., Zhang Q., Liu F., Li J., Bi S. other authors 2008; Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo. J Med Virol 80:1171–1180 [CrossRef]
   [Google Scholar]
8. Chen H., Cantrell C. R. 2006; Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis. Curr Med Res Opin 22:2489–2496 [CrossRef]
   [Google Scholar]
9. Emerson S. U., Huang Y. K., Purcell R. H. 1993; 2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture. Virology 194:475–480 [CrossRef]
   [Google Scholar]
10. Endo K., Takahashi M., Masuko K., Inoue K., Akahane Y., Okamoto H. 2007; Full-length sequences of subgenotype IIIA and IIIB hepatitis A virus isolates: characterization of genotype III HAV genomes. Virus Res 126:116–127 [CrossRef]
    [Google Scholar]
11. Gauss-Muller V., Lottspeich F., Deinhardt F. 1986; Characterization of hepatitis A virus structural proteins. Virology 155:732–736 [CrossRef]
    [Google Scholar]
12. Gosert R., Egger D., Bienz K. 2000; A cytopathic and a cell culture adapted hepatitis A virus strain differ in cell killing but not in intracellular membrane rearrangements. Virology 266:157–169 [CrossRef]
    [Google Scholar]
13. Jelic O., Fornet-Sapcevski J., Kovacevic L., Pandak N., Jelic D. 1990; Recurrences of viral hepatitis A. Acta Med Iugosl 44:565–576
    [Google Scholar]
14. Kim S. J., Jang M. H., Stapleton J. T., Yoon S. O., Kim K. S., Jeon E. S., Hong H. J. 2004; Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage display. Virology 318:598–607 [CrossRef]
    [Google Scholar]
15. Konduru K., Virata-Theimer M. L., Yu M. Y., Kaplan G. G. 2008; A simple and rapid hepatitis A virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations. Virol J 5:155 [CrossRef]
    [Google Scholar]
16. Lemon S. M., Murphy P. C., Shields P. A., Ping L. H., Feinstone S. M., Cromeans T., Jansen R. W. 1991; Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination. J Virol 65:2056–2065
    [Google Scholar]
17. Lemon S. M., Jansen R. W., Brown E. A. 1992; Genetic, antigenic and biological differences between strains of hepatitis A virus. Vaccine 10:S40–S44 [CrossRef]
    [Google Scholar]
18. Nainan O. V., Xia G., Vaughan G., Margolis H. S. 2006; Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev 19:63–79 [CrossRef]
    [Google Scholar]
19. Pinto R. M., Aragones L., Costafreda M. I., Ribes E., Bosch A. 2007; Codon usage and replicative strategies of hepatitis A virus. Virus Res 127:158–163 [CrossRef]
    [Google Scholar]
20. Sanchez G., Populaire S., Butot S., Putallaz T., Joosten H. 2006; Detection and differentiation of human hepatitis A strains by commercial quantitative real-time RT-PCR tests. J Virol Methods 132:160–165 [CrossRef]
    [Google Scholar]
21. Shouval D., Ashur Y., Adler R., Lewis J. A., Armstrong M. E., Davide J. P., McGuire B., Kuter B., Brown L. other authors 1993; Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis. Vaccine 11:S9–S14 [CrossRef]
    [Google Scholar]
22. Siegl G., Dechastonay J., Kronauer G. 1984; Propagation and assay of hepatitis A virus in vitro. J Virol Methods 9:53–67 [CrossRef]
    [Google Scholar]
23. Stapleton J. T., Raina V., Winokur P. L., Walters K., Klinzman D., Rosen E., McLinden J. H. 1993; Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles. J Virol 67:1080–1085
    [Google Scholar]
24. Yeh H. Y., Hwang Y. C., Yates M. V., Mulchandani A., Chen W. 2008; Detection of hepatitis A virus by using a combined cell culture–molecular beacon assay. Appl Environ Microbiol 74:2239–2243 [CrossRef]
    [Google Scholar]
25. Zahn J., Vallbracht A., Flehmig B. 1984; Hepatitis A-virus in cell culture. V. Neutralizing antibodies against hepatitis A-virus. Med Microbiol Immunol 173:9–17 [CrossRef]
    [Google Scholar]